Clinical Trial Update: First-in-Human Study of ICT01 in Patients With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

First-in-human study of ICT01 in patients with advanced cancer; Phase 1/2 trial, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• ICT01

Snippet

Sponsor: ImCheck Therapeutics | Conditions: Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING